I don't think becoming CF+ is going to have huge effect on share...

I don't think becoming CF+ is going to have huge effect on share price or the business - maybe a few cents and that's about it. Unless they secure significant contracts with solid revenue it will continue to hover around the 10-15c mark.

We had the capital raise $3.5M Strategic Financial Package for Kojensi US Expansion announced 2nd Dec and I certainly hope it is actually used for that purpose unlike the previous capital raise.

• We had a ~$400k contract sept last year with Dept Health
• We had the $7M contract(over 2 years) with Defence announced June last year which is activated by issuance of work orders for varying amounts and hopefully we will get to the $7M by June 24.
• We saw archTIS Awarded $449K Contract Oct-21 (for 12 months) with an Australian National Intelligence and Law Enforcement Agency with option to extend over the following 5 years but have not seen any announcement of continuation.
• announced May-21 archTIS Secures $535k Contract(over 5 years) to Expand the Deployment of NC Protect within an Australian Commonwealth National Security Agency
• and the May-21 announcement archTIS Wins $296K Contract with Australian Department of Defence paid up front for 2 months work.

That's it for the past 2 years for any major(?) contracts. Not sue if we label anything under $0.5M as a major contract.

We need to see contracts in the $M's and also the tens of $M's. There's only been one in the last 2 years. There is something seriously problematic with their marketing and Sales. If we assume that the raised $3.5M will be handled by Kurt in the US to expand Kojensi then we have some hope. However I then question what sales and marketing effort is being expended elsewhere to diversify and sectorial and geographically? If I hear again that it takes time to have marketing effort to mature into material contracts , I think I will vomit.

It's revenue or flounder around 10c.